Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings

NCT00603954 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

DRUG: Conditioning regimen: TBI + Fludarabine
DRUG: Conditioning regimen:TLI (8 Gy) + ATG

Sponsor

University of Liege

Collaborators

[object Object]
[object Object]